SORT-OUT VI - Randomized Clinical Comparison of Biomatrix Flex® and Resolute Integrity®
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2800 participants.
Also called NCT01956448
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,800 participants
- Registry
-
NCT01956448
-
- Other papers using this trial's data
- Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial
- Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Denmark
- Registry status
- Completed
Technical summary
Registry record NCT01956448. Randomized; no masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2012-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- SORT-OUT VI - Randomized Clinical Comparison of Biomatrix Flex® and Resolute Integrity®
- Acronym
- SO VI
- Condition
- Coronary Artery Disease
- Condition
- Angina Pectoris
- Intervention (Device)
- Drug eluting stent
- Lead sponsor
- Aarhus University Hospital Skejby
- Collaborator
- Biosensors International
- Collaborator
- Medtronic Cardiovascular
Record details
- Record id
cardio:ct-nct01956448- Content hash
226ae26e2e92aae097c7a3389667aae06a67b47500366cb4330c654d60f9ddcb